by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Merrill Lynch Wealth Management is revamping its leadership structuring, paring its 10 divisions down to six in the process, according to an internal memo obtained by CNBC. Andy Sieg, head of Merrill Lynch Wealth Management, said the changes “will help us...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Synovus Financial Corp. will buy the financial unit of outdoor goods retailer Cabela’s Inc., a source familiar with the matter told Reuters. Synovus will keep the deposits held by the unit and resell its credit-card portfolio to Capital One Financial Corp., the...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Shares of Vulcan Materials rose 3 percent Wednesday on expectations for increased highway and repair spending in California. Vulcan, one of the nation’s largest producers of construction aggregates, could benefit from California roadwork funding, according to a...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Robots and artificial intelligence are going to pose a major threat to jobs in the coming years, Martin Ford, author of “Rise of the Robots: Technology & the Jobless Future,” told CNBC on Wednesday. “Machines are encroaching on the fundamental...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
The nation’s top military official in the Middle East on Wednesday said Iran is one of the greatest threats to the U.S. today and has increased its “destabilizing role” in the region. “I believe that Iran is operating in what I call a gray...
by synergycap1 | Mar 29, 2017 | Bad Credit Loans, Bank Lending, Bureau of Labor Statistics, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Mylan said on Wednesday its application to market a generic copy of GlaxoSmithKline’s blockbuster inhaled lung drug Advair was rejected by the U.S. Food and Drug Administration. Mylan’s shares fell nearly 2 percent to $40.90 in afternoon trading. The FDA...
